Integer Holdings Corp (ITGR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Integer Holdings Corp (ITGR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6545
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, laparoscopic and general surgery, biopsy and drug delivery, orthopedic, cardiac rhythm management and neuromodulation; vascular access products, and others. Its cardiac rhythm management and neuromodulation products comprise batteries, capacitors, catheters, coated electrodes, device headers, device enclosures, battery and capacitors cases; feedthroughs and filtered feedthroughs, leads therapy development components, accessories, and others. Greatbatch offers orthopedic products such as hip replacements, silicone handles and delivery systems, among others. The company has operations in the US, Switzerland, Mexico, France, Germany, Ireland, and Uruguay, among others. Greatbatch is headquartered in Frisco, Texas, the US.

Integer Holdings Corp (ITGR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Integer Holdings Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Integer Holdings Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Integer Holdings Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Integer Holdings Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Integer Holdings Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Integer Holdings Corp, Medical Equipment, Deal Details 11
Venture Financing 11
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 11
Aleva Neurotherapeutics to Raise Funds in Series C Financing 13
Cardionomic Raises USD20 Million in Series A Financing Round 14
Partnerships 15
Greatbatch Extends its Licensing Agreement with WiTricity 15
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 16
ECA Medical Instruments Enters Into Distribution Agreement With Greatbatch Medical For Orthopedic Surgical Instruments 17
Debt Offering 18
Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 18
Asset Transactions 19
MedPlast Acquires Advanced Surgical and Orthopedics Product Lines from Integer for USD600 Million 19
Acquisition 21
Greatbatch Acquires Lake Region Medical for USD1.73 Billion 21
Greatbatch Acquires C.C.C. Del Uruguay for USD18 Million 23
Accellent Completes Acquisition Of Lake Region Medical, Manufacturer Of Medical Devices 24
Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company 26
Integer Holdings Corp – Key Competitors 27
Integer Holdings Corp – Key Employees 28
Integer Holdings Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 32
Financial Announcements 32
Aug 02, 2018: Integer Holdings reports second quarter 2018 results 32
May 03, 2018: Integer Holdings Reports First Quarter 2018 Results 33
Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 35
Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 36
Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 38
May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 39
Feb 27, 2017: Integer Holdings Reports Results for Fourth Quarter and Full Year 2016 40
Corporate Communications 43
Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 43
Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 44
Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 45
Mar 27, 2017: Integer Announces Leadership Change 46
Feb 27, 2017: Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer 47
Other Significant Developments 48
Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Integer Holdings Corp, Medical Equipment, Key Facts, 2017 2
Integer Holdings Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Integer Holdings Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Integer Holdings Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Integer Holdings Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Integer Holdings Corp, Deals By Market, 2012 to YTD 2018 9
Integer Holdings Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 11
Aleva Neurotherapeutics to Raise Funds in Series C Financing 13
Cardionomic Raises USD20 Million in Series A Financing Round 14
Greatbatch Extends its Licensing Agreement with WiTricity 15
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 16
ECA Medical Instruments Enters Into Distribution Agreement With Greatbatch Medical For Orthopedic Surgical Instruments 17
Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 18
MedPlast Acquires Advanced Surgical and Orthopedics Product Lines from Integer for USD600 Million 19
Greatbatch Acquires Lake Region Medical for USD1.73 Billion 21
Greatbatch Acquires C.C.C. Del Uruguay for USD18 Million 23
Accellent Completes Acquisition Of Lake Region Medical, Manufacturer Of Medical Devices 24
Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company 26
Integer Holdings Corp, Key Competitors 27
Integer Holdings Corp, Key Employees 28
Integer Holdings Corp, Other Locations 29
Integer Holdings Corp, Subsidiaries 30

List of Figures
Integer Holdings Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Integer Holdings Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Integer Holdings Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Integer Holdings Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Integer Holdings Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Integer Holdings Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Integer Holdings Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Integer Holdings Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Integer Holdings Corp (ITGR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • X-Chem Inc-製薬・医療分野:企業M&A・提携分析
    Summary X-Chem Inc (X-Chem) is a biotechnology company that focuses on applying its innovative drug discovery platform to the generation of novel small molecule therapeutics. The company’s drug discovery engine is based on a library generated by iterative combinatorial synthesis of small molecules. …
  • Matrai Eromu ZRt:企業の戦略的SWOT分析
    Matrai Eromu ZRt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Green Cross Cell Corp (031390)-製薬・医療分野:企業M&A・提携分析
    Summary Green Cross Cell Corp (Green Cross Cell), formerly Innocell Corp, a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offer …
  • Esperion Therapeutics Inc (ESPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Pedernales Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Pedernales Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Crossject SA (ALCJ):医療機器:M&Aディール及び事業提携情報
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company’s pipeline products include sumatriptan for the treatment of migraines and cluster headaches; adrenaline for the treatment of anaphylactic shock; hydrocortisone for the treatment of acute adrena …
  • NMDC Ltd:企業のM&A・事業提携・投資動向
    NMDC Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NMDC Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Skipton Building Society (SKIP):企業の財務・戦略的SWOT分析
    Skipton Building Society (SKIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • DNO ASA (DNO):企業の財務・戦略的SWOT分析
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It operates its oil and gas producing assets lo …
  • Eguana Technologies Inc. (EGT):電力:M&Aディール及び事業提携情報
    Summary Eguana Technologies Inc. (Eguana), formerly Sustainable Energy Technologies Ltd, is a power electronics company that designs, manufactures and supplies high performance power control solutions for grid interactive energy storage systems. The company’s power control solutions charge and disch …
  • John Wiley & Sons, Inc.:企業のM&A・事業提携・投資動向
    John Wiley & Sons, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's John Wiley & Sons, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • ZoomMed Inc (ZMD):医療機器:M&Aディール及び事業提携情報
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • BioDiem Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal dis …
  • Rockwell Collins Inc:企業のM&A・事業提携・投資動向
    Rockwell Collins Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rockwell Collins Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Quanterix Corp (QTRX):医療機器:M&Aディール及び事業提携情報
    Summary Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa …
  • Ocular Therapeutix Inc (OCUL):企業の製品パイプライン分析2018
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • Esterline Technologies Corporation:企業の戦略・SWOT・財務情報
    Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Ferring Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferring Pharmaceuticals Inc (Ferring), a subsidiary of Ferring International Center SA is a biopharmaceutical company that conducts research and development services. The company develops peptide-based drugs and biotechnology derived medicines. It also develops effective and patient-friendly …
  • Monsoon Accessorize Ltd:企業の戦略・SWOT・財務分析
    Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report Summary Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆